# Cocrystal Pharma, Inc.

Canonical: https://abierto.us/vendors/cocrystal-pharma-inc-uy8udesgrj17

- UEI: UY8UDESGRJ17
- CAGE: 7SGF5
- Location: Bothell, WA
- Awards in window: 1 (1 transactions), $498,199 obligated, September 29, 2025 to September 29, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $498,199

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $498,199

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N93025C00038 (definitive contract): $498,199, National Institutes of Health Niaid. Development of Pan-Influenza Inhibitors Targeting the PA Endonuclease from the Viral Replication Complex. https://www.usaspending.gov/award/CONT_AWD_75N93025C00038_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cocrystal-pharma-inc-uy8udesgrj17.